233 related articles for article (PubMed ID: 21641678)
1. Monotherapy with inhaled colistin for the treatment of patients with ventilator-associated tracheobronchitis due to polymyxin-only-susceptible Gram-negative bacteria.
Athanassa ZE; Myrianthefs PM; Boutzouka EG; Tsakris A; Baltopoulos GJ
J Hosp Infect; 2011 Aug; 78(4):335-6. PubMed ID: 21641678
[No Abstract] [Full Text] [Related]
2. Inhaled colistimethate sodium in ventilator-associated tracheobronchitis due to multidrug-resistant Gram-negative bacteria.
Maskin LP; Setten M; Rodríguez PO; Bonelli I; Attie S; Stryjewski ME; Valentini R
Int J Antimicrob Agents; 2015 Feb; 45(2):199-200. PubMed ID: 25459739
[No Abstract] [Full Text] [Related]
3. Multidrug-resistant Gram-negative infections: the use of colistin.
Michalopoulos AS; Karatza DC
Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1009-17. PubMed ID: 20818945
[TBL] [Abstract][Full Text] [Related]
4. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A
Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients.
Athanassa ZE; Markantonis SL; Fousteri MZ; Myrianthefs PM; Boutzouka EG; Tsakris A; Baltopoulos GJ
Intensive Care Med; 2012 Nov; 38(11):1779-86. PubMed ID: 22810779
[TBL] [Abstract][Full Text] [Related]
6. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
[TBL] [Abstract][Full Text] [Related]
7. Use of colistin in children.
Tamma PD; Lee CK
Pediatr Infect Dis J; 2009 Jun; 28(6):534-5. PubMed ID: 19483519
[No Abstract] [Full Text] [Related]
8. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
[TBL] [Abstract][Full Text] [Related]
9. Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B.
Pereira GH; Muller PR; Levin AS
Diagn Microbiol Infect Dis; 2007 Jun; 58(2):235-40. PubMed ID: 17350201
[TBL] [Abstract][Full Text] [Related]
10. Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis.
Falagas ME; Sideri G; Korbila IP; Vouloumanou EK; Papadatos JH; Kafetzis DA
Pediatr Pulmonol; 2010 Nov; 45(11):1135-40. PubMed ID: 20658485
[TBL] [Abstract][Full Text] [Related]
11. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections.
Huang J; Tang YQ; Sun JY
Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections.
Cheng CY; Sheng WH; Wang JT; Chen YC; Chang SC
Int J Antimicrob Agents; 2010 Mar; 35(3):297-300. PubMed ID: 20045293
[TBL] [Abstract][Full Text] [Related]
13. Difficult-to-treat Gram-negative bone and joint infections: efficacy and safety of prolonged intravenous colistin.
Valour F; Dutronc H; Dinh A; Cazorla C; Pavèse P; Lesens O; Uçkay I; Chidiac C; Ferry T;
Int J Antimicrob Agents; 2013 Feb; 41(2):197-9. PubMed ID: 23146203
[No Abstract] [Full Text] [Related]
14. The importance of protecting the mechanical ventilator during colistin methanesulfonate nebulization.
Mojoli F; Iotti GA; Imberti R; Braschi A
Intensive Care Med; 2013 Mar; 39(3):535-6. PubMed ID: 23263028
[No Abstract] [Full Text] [Related]
15. Multidrug-resistant Gram-negative bacteria: how to treat and for how long.
Giamarellou H
Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S50-4. PubMed ID: 21129924
[TBL] [Abstract][Full Text] [Related]
16. Intravenous colistimethate for multidrug-resistant Gram-negative bacteria.
Zavascki AP; Li J
Lancet Infect Dis; 2008 Jul; 8(7):403-5. PubMed ID: 18582831
[No Abstract] [Full Text] [Related]
17. Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin.
Hamer DH
Am J Respir Crit Care Med; 2000 Jul; 162(1):328-30. PubMed ID: 10903263
[TBL] [Abstract][Full Text] [Related]
18. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients.
Falagas ME; Rafailidis PI; Ioannidou E; Alexiou VG; Matthaiou DK; Karageorgopoulos DE; Kapaskelis A; Nikita D; Michalopoulos A
Int J Antimicrob Agents; 2010 Feb; 35(2):194-9. PubMed ID: 20006471
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of colistin against multidrug-resistant gram-negative bacteria isolated at a major army hospital during the military campaigns in Iraq and Afghanistan.
Paolino K; Erwin D; Padharia V; Carrero H; Giron L; Burgess R; Burger C; Martinez M; Arrieta P; Wortmann G; Zapor M
Clin Infect Dis; 2007 Jul; 45(1):140-1. PubMed ID: 17554723
[No Abstract] [Full Text] [Related]
20. Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients.
Kontopidou F; Plachouras D; Papadomichelakis E; Koukos G; Galani I; Poulakou G; Dimopoulos G; Antoniadou A; Armaganidis A; Giamarellou H
Clin Microbiol Infect; 2011 Nov; 17(11):E9-E11. PubMed ID: 21939468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
